Clinical Trial Update: Evaluation of the Effect of Vivostat Platelet Rich Fibrin(PRF) in the Treatment of Diabetic Foot Ulcers [Phase 4]

View source ↗

Summary

An update reporting the completion of a Phase 4 trial evaluating Vivostat Platelet Rich Fibrin (PRF) for the treatment of diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• Vivostat Platelet Rich Fibrin (platelet-rich fibrin)

Snippet

Sponsor: Vivostat | Conditions: Diabetic Foot Ulcers | Phase 4 | Status: COMPLETED